Results 111 to 120 of about 125,028 (162)
Some of the next articles are maybe not open access.
Pharmacologic Therapies in Anticoagulation
Medical Clinics of North America, 2016Anticoagulants are beneficial for prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation. The development of target-specific oral anticoagulants is changing the landscape of anticoagulation therapy and created growing interest on this subject.
Joana Lima, Ferreira, Joyce E, Wipf
openaire +2 more sources
Electroconvulsive Therapy and Anticoagulation
Psychosomatics, 2019[No abstract available]
Gökcek, Aysel +4 more
openaire +2 more sources
Anticoagulation Therapy in Children
Pediatric Drugs, 2003Thromboembolic disease (TED) is increasingly recognized as a major cause of morbidity and mortality in tertiary pediatrics. Children younger than 1 year of age and teenage girls are at greatest risk of thromboembolism. Although anticoagulation therapy is the treatment of choice for TED, the treatment strategy is often difficult, especially in children.
Milind D, Ronghe +2 more
openaire +4 more sources
Development in anticoagulant therapy
Critical Reviews in Oncology/Hematology, 2008Venous thromboembolism is an important clinical problem. Cancer patients have higher risk to develop venous thrombosis and vice versa. The treatment consists of heparin followed by vitamin K antagonists. Both agents have several limitations. Especially in cancer patients, vitamin K antagonists cause bleeding or recurrence of VTE because of a small ...
F F, van Doormaal +2 more
openaire +2 more sources
Anticoagulant therapy in pregnancy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999Anticoagulation during pregnancy should derive benefit from recent advances in anticoagulant therapy. Unfractionated heparin is at present the drug of choice for most of the indications of thromboprophylaxis as well as for acute venous thrombosis during pregnancy but it is likely that, in the near future, low molecular weight heparins will supercede ...
F, Robin +4 more
openaire +2 more sources
An Evaluation of Anticoagulant Therapy
Cardiologia, 1953Abstract 1.1. During the past decade the indications for anticoagulant therapy have been clarified. They are listed herein. 2.2. In view of the reduction in both death rate and in the incidence of thromboembolic complications following coronary thrombosis with myocardial infarction with the use of anticoagulants in mild and moderately severe cases,
openaire +3 more sources
Indications for anticoagulant therapy
American Heart Journal, 1969Abstract The value of anticoagulant therapy is solidly established in the presence of deepvein thrombosis and pulmonary embolism, in the presence of recurrent cerebral ischemic episodes when reparative vascular surgery is not possible, and in postoperative and bedridden patients, at least those with a high risk of pulmonary embolism.
A F, Lyon, A C, DeGraff
openaire +2 more sources
Anticoagulation Therapy in Children
Seminars in Thrombosis and Hemostasis, 2017AbstractVenous thromboembolism (VTE) is very uncommon in children and adolescents compared with older adults, though its incidence has significantly increased over the past two decades. Given the rarity of the condition, the data on pediatric VTE lag behind the adult experience and consequently the management of VTE in children is, in large part ...
openaire +2 more sources
Indications for Anticoagulant Therapy
New England Journal of Medicine, 1963THE place of anticoagulant therapy in the various types and phases of occlusive vascular disease, venous and arterial, has been debated ever since its introduction into clinical practice more than fifteen years ago. The widely divergent opinions and seemingly conflicting results of therapeutic trials that have appeared are unmistakable symptoms of ...
openaire +3 more sources
Advances in anticoagulation therapy
JAAPA, 2018ABSTRACT Because atrial fibrillation (AF) is a major risk for thrombotic disease, many patients with AF are managed with anticoagulation for primary or secondary prevention of these events. The emergence of novel oral anticoagulants offers patients and providers options to consider beyond warfarin.
Emily, Webster, Michael, Gil
openaire +2 more sources